Wave Life Sciences, Inc.
▲ 3 upgrades / ▼ 0 downgrades / 0 reiterations from 3 firms
Nov 9, 2026 (14 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 16, 2026 | William Blair | initiate | — → Outperform | — | 48% |
| Oct 15, 2026 | UBS | initiate | — → Buy | — | 54% |
| Oct 1, 2026 | Ladenburg Thalmann | initiate | — → Buy | — | 45% |
| Sep 23, 2026 | JP Morgan | downgrade | Overweight → Neutral | — | 55% |
| Aug 4, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Jul 31, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Jul 31, 2026 | B. Riley Securities | maintain | Buy → Buy | — | 54% |
| Jul 31, 2026 | Wedbush | maintain | Outperform → Outperform | — | 58% |
| May 20, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| May 19, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| May 4, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Apr 30, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Apr 29, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Apr 14, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Mar 27, 2026 | B of A Securities | maintain | Buy → Buy | — | 53% |
| Mar 27, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| Mar 25, 2026 | Mizuho | maintain | Outperform → Outperform | $27 | 52% |
| Mar 10, 2026 | Canaccord Genuity | maintain | Buy → Buy | $52 | 48% |
| Mar 6, 2026 | Wedbush | maintain | Outperform → Outperform | $35 | 58% |
| Mar 2, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | $30 | 44% |
| Feb 12, 2026 | Wells Fargo | maintain | Overweight → Overweight | $27 | 54% |
| Feb 5, 2026 | Cantor Fitzgerald | maintain | Overweight → Overweight | $41 | 50% |
| Feb 3, 2026 | Canaccord Genuity | maintain | Buy → Buy | $43 | 48% |
| Dec 19, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $30 | 44% |
| Dec 16, 2025 | Oppenheimer | maintain | Outperform → Outperform | $32 | 52% |
| Dec 15, 2025 | Truist Securities | maintain | Buy → Buy | $50 | 54% |
| Dec 12, 2025 | B. Riley Securities | maintain | Buy → Buy | $37 | 54% |
| Dec 12, 2025 | Wedbush | maintain | Outperform → Outperform | $33 | 58% |
| Dec 9, 2025 | Citigroup | maintain | Buy → Buy | $30 | 54% |
| Dec 9, 2025 | Canaccord Genuity | maintain | Buy → Buy | $40 | 48% |
| Dec 9, 2025 | Wells Fargo | maintain | Overweight → Overweight | $29 | 54% |
| Dec 9, 2025 | Cantor Fitzgerald | maintain | Overweight → Overweight | $34 | 50% |
| Dec 9, 2025 | Clear Street | maintain | Buy → Buy | $47 | 48% |
| Dec 9, 2025 | RBC Capital | upgrade | Sector Perform → Outperform | $27 | 55% |
| Nov 11, 2025 | Wedbush | maintain | Outperform → Outperform | $20 | 58% |
| Nov 11, 2025 | Wells Fargo | maintain | Overweight → Overweight | $16 | 54% |
| Oct 15, 2025 | Clear Street | initiate | — → Buy | $22 | 48% |
| Sep 4, 2025 | Wells Fargo | maintain | Overweight → Overweight | $18 | 54% |
| Sep 3, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $22 | 44% |
| Aug 4, 2025 | Canaccord Genuity | initiate | — → Buy | $19 | 48% |
| Jul 31, 2025 | Wells Fargo | maintain | Overweight → Overweight | $21 | 54% |
| Jul 28, 2025 | Oppenheimer | initiate | — → Outperform | $24 | 52% |
| Jul 16, 2025 | Citigroup | initiate | — → Buy | $16 | 54% |
| Jun 23, 2025 | Wedbush | reiterate | Outperform → Outperform | $18 | 58% |
| Apr 29, 2025 | Cantor Fitzgerald | initiate | — → Overweight | $10 | 50% |
| Mar 26, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $22 | 44% |
| Mar 5, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $22 | 44% |
| Feb 25, 2025 | Jefferies | initiate | — → Buy | $26 | 52% |
| Nov 21, 2024 | Mizuho | maintain | Outperform → Outperform | $22 | 52% |
| Nov 13, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $22 | 44% |
No cross-platform signals in the last 90 days